logo
  • Home
  • People, Patients, Loved Ones
    • NHF Blog
    • HeadWise™ Podcast
    • Complete Headache Chart
    • Living With Migraine™
    • Migraine University©
    • Patient Assistance Programs
    • Disability Benefits
    • Clinical Trials
    • Publications
    • Webinars
    • NHF On the Job™
  • Military Community
  • Find a Provider
  • Donate
  • Healthcare Practitioners & Researchers
    • AQH Certification
    • Research
    • Primary Care Migraine™
  • Action4Access™
  • Home
  • People, Patients, Loved Ones
    • NHF Blog
    • HeadWise™ Podcast
    • Complete Headache Chart
    • Living With Migraine™
    • Migraine University©
    • Patient Assistance Programs
    • Disability Benefits
    • Clinical Trials
    • Publications
    • Webinars
    • NHF On the Job™
  • Military Community
  • Find a Provider
  • Donate
  • Healthcare Practitioners & Researchers
    • AQH Certification
    • Research
    • Primary Care Migraine™
  • Action4Access™

Atogepant and Migraine

October 2021, Episode 103: Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. On this episode of Heads UP, Dr. Lindsay Weitzel asks migraine clinical trial expert Dr. Tim Smith all the hard…

Read More

medications

Treatment Optimization and Medication Side Effects

July 2020, Episode 63: Do you feel your migraine treatment options are limited because you experience numerous side effects to multiple medications? Dr. Lindsay Weitzel talks to Dr. Vince Martin about how to optimize your treatment plan if you are…

Read More

National Headache Foundation Logo

The National Headache Foundation is a 501(c)(3) tax exempt organization.

Learn More

  • NHF Blog
  • About
  • Contact Us
  • Donate

Contact Us

162 W. Hubbard Street, Suite 500
Chicago, Illinois 60654

Phone: 312.274.2650
Toll-Free: 888-NHF-5552 (888-643-5552)
Email: [email protected]

HeadWise Podcast

© 2025 National Headache Foundation. All Rights Reserved. Website by CyberOptik

Star Rating Badge Full Color
candid seal platinum 2025
  • Financials
  • Terms
  • Privacy Policy
  • Disclaimer